STOCK TITAN

Horizon Space Acquisition II (HSPT) Stock News

HSPT Nasdaq

Welcome to our dedicated page for Horizon Space Acquisition II news (Ticker: HSPT), a resource for investors and traders seeking the latest updates and insights on Horizon Space Acquisition II stock.

Horizon Space Acquisition II Corp. reports developments as a blank-check company focused on completing an initial business combination. News about HSPT centers on SPAC governance, shareholder voting matters, charter and deadline-extension actions, material agreements, and capital-structure disclosures tied to its ordinary shares, units, and rights. Updates also address risk factors and operating or financial results typical of a pre-combination issuer.

Rhea-AI Summary

Horizon Space Acquisition II (NASDAQ: HSPT) clarified redemption instructions for two upcoming shareholder meetings: the Business Combination Meeting on Feb 12, 2026 and the Extension Meeting on Feb 13, 2026. Public shareholders must instruct the transfer agent to redeem shares for the Extension Meeting by 5:00 p.m. ET on Feb 11, 2026 to ensure redemption if either action is implemented. The Business Combination Meeting redemption deadline remains 5:00 p.m. ET on Feb 10, 2026, and meeting logistics and the record date are unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
-
Rhea-AI Summary

Horizon Space Acquisition II Corp (NASDAQ: HSPT) postponed its Extraordinary General Meeting from 9:00 a.m. ET on February 3, 2026 to 9:00 a.m. ET on February 12, 2026 to allow additional shareholder engagement. There is no change to location, record date (Dec 29, 2025) or meeting proposals.

The physical meeting remains at Robinson & Cole LLP, 666 Third Avenue, 20th Floor, New York, NY, and will be available via teleconference. The public shareholder redemption request deadline is extended to 5:00 p.m. ET on February 10, 2026. Contact information for transfer agent and proxy solicitor was provided for shareholder questions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
-
Rhea-AI Summary
Horizon Space Acquisition II Corp. (NASDAQ: HSPT) has announced a definitive business combination agreement with SL Bio Ltd., a clinical-stage biomedical company. The merger will result in SL Bio becoming publicly listed on the Nasdaq under a new entity, SL Science Holding Limited. SL Bio specializes in developing cellular and gene therapies for cancer treatment and regenerative medicine, featuring proprietary platforms including Armed-T and Gamma Delta T cell technologies. The company's pipeline targets blood cancers, pancreatic cancer, and brain cancer. Additionally, SL Bio develops cow milk-derived exosomes and citrus reticulata extract for skin and hair care applications. The combined company will be led by CEO William Wang, with Johnson Lau as CFO and Dr. Ethan Shen as CTO. The transaction is expected to close by late 2025, subject to regulatory and shareholder approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Horizon Space Acquisition II Corp. (NASDAQ: HSPT) has announced that starting February 5, 2025, holders of the 5,750,000 units sold in its initial public offering can begin separately trading the ordinary shares and rights included in the Units. The Units, which include those sold during the full exercise of the underwriters' over-allotment option, will continue trading on NASDAQ under 'HSPTU,' while separated ordinary shares and rights will trade under 'HSPT' and 'HSPTR' respectively.

Unit holders must contact their brokers and the company's transfer agent, VStock Transfer , to separate their units. The initial public offering was underwritten by Maxim Group , following an SEC-approved registration statement (File No. 333-282758) effective November 12, 2024. The offering was conducted solely through a prospectus available through Maxim Group or the SEC's EDGAR system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Horizon Space Acquisition II (HSPT)?

The current stock price of Horizon Space Acquisition II (HSPT) is $8.81 as of May 13, 2026.

What is the market cap of Horizon Space Acquisition II (HSPT)?

The market cap of Horizon Space Acquisition II (HSPT) is approximately 44.5M.